July 24, 2026
9 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Executives from the largest U.S. health care payers cited proactive management of high-risk patients, biosimilar use and site-of-care steerage as their top tactics to lower care costs, according to a survey from Spherix Global Insights.Spherix surveyed 27 decision-makers from nine of the leading managed care organizations and pharmacy benefit managers (PBMs) in the United States: UnitedHealth
July 24, 2026
9 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Beyond the Contract: The Operational Infrastructure Behind Trusted Payer-Provider Partnership

The next step of site-neutral, and a fiery PBM hearing

UST HealthProof/HealthEdge Tops Black Book Payer IT Consulting Study

What's behind Aetna's investments to build provider trust

GLP-1s and the High Cost of Providing Health Care

Congress is finally taking on the middlemen driving up your drug costs

Drug spending is rising sharply, with high-cost GLP-1 medications driving nearly half of the incr | How RxSense helped a health…

As healthcare costs continue to spike in the U.S | Though 47% of respondents point the finger at corporate health insurers,…

As medical costs continue to rise, employers are weighing a return to policies that shift additional expense to workers,…

LAS VEGAS — As drug costs and spending continue to rise, the demand for solutions opens the door to closer collaboration between…

Healthcare costs continue to rise, making effective payer-provider collaboration more important than ever. Download this free…

As the health insurance industry continues to face significant headwinds and challenges, the CEOs of major firms largely stayed…